These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30689127)

  • 1. Anticoagulation in CKD and ESRD.
    Leung KC; MacRae JM
    J Nephrol; 2019 Oct; 32(5):719-731. PubMed ID: 30689127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.
    Douketis JD; Crowther MA; Cherian SS
    Can J Cardiol; 2000 Mar; 16(3):326-30. PubMed ID: 10744795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of low-molecular-weight heparin compared to unfractionated heparin in hemodialysis: a systematic review and meta-analysis.
    Lazrak HH; René É; Elftouh N; Leblanc M; Lafrance JP
    BMC Nephrol; 2017 Jun; 18(1):187. PubMed ID: 28592259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
    Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral anticoagulation in chronic kidney disease with atrial fibrillation].
    Expósito V; Seras M; Fernández-Fresnedo G
    Med Clin (Barc); 2015 May; 144(10):452-6. PubMed ID: 24889748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
    Nishimura M; Hsu JC
    Am J Cardiol; 2018 Jan; 121(1):131-140. PubMed ID: 29132650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal anticoagulation duration of unfractionated and low molecular weight heparin in non-ST elevation acute coronary syndrome: a systematic review of the literature.
    Riaz IB; Asawaeer M; Riaz H; Gabriel WM; Tabash IK; Bilal J; Alpert JS
    Int J Cardiol; 2014 Dec; 177(2):461-6. PubMed ID: 25443247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
    Keskar V; Sood MM
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2085-2092. PubMed ID: 27797891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK prescribing practice of anticoagulants in patients with chronic kidney disease: a nephrology and haematology-based survey.
    Parker K; Choudhuri S; Lewis P; Thachil J; Mitra S
    BMC Nephrol; 2023 Jan; 24(1):9. PubMed ID: 36635661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unfractionated heparin and low molecular weight heparin for acute coronary syndromes--assessment of a Cochrane review].
    Husted SE; Nielsen HK
    Ugeskr Laeger; 2010 Sep; 172(37):2522-6. PubMed ID: 20836961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?
    Kalra PA; Burlacu A; Ferro CJ; Covic A
    Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):420-425. PubMed ID: 30020140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporotic fracture rates in chronic hemodialysis and effect of heparin exposure: a retrospective cohort study.
    Harrak H; René E; Alsalemi N; Elftouh N; Lafrance JP
    BMC Nephrol; 2020 Jul; 21(1):261. PubMed ID: 32646504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with atrial fibrillation and chronic kidney disease in light of the latest guidelines.
    Młodawska E; Tomaszuk-Kazberuk A; Łopatowska P; Musiał WJ; Małyszko J
    Pol Arch Med Wewn; 2016 May; 126(5):353-62. PubMed ID: 27243343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.